Company Information & Drug Savings for X4 Pharmaceuticals Medications
X4 Pharmaceuticals is a biopharmaceutical company developing novel therapies for rare diseases by targeting the CXCR4 pathway. Based in Boston, the company created Xolremdi (mavorixafor) for WHIM syndrome, a rare immunodeficiency disorder. X4’s CXCR4 inhibitor research addresses immune dysregulation in rare genetic conditions.
How to Contact X4 Pharmaceuticals
Phone
1-857-529-8300Medical Disclaimer
NowPatient has taken all reasonable steps to ensure that all material is factually accurate, complete, and current. However, the knowledge and experience of a qualified healthcare professional should always be sought after instead of using the information on this page. Before taking any drug, you should always speak to your doctor or another qualified healthcare provider.
The information provided here about medications is subject to change and is not meant to include all uses, precautions, warnings, directions, drug interactions, allergic reactions, or negative effects. The absence of warnings or other information for a particular medication does not imply that the medication or medication combination is appropriate for all patients or for all possible purposes.
Experienced a Side Effect?
Report to Yellow Card (UK) or MedWatch (US)
